Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Effects of fluconazole on the secretome, the wall proteome, and wall integrity of the clinical fungus Candida albicans.

Sorgo AG, Heilmann CJ, Dekker HL, Bekker M, Brul S, de Koster CG, de Koning LJ, Klis FM.

Eukaryot Cell. 2011 Aug;10(8):1071-81. doi: 10.1128/EC.05011-11. Epub 2011 May 27.

PMID:
21622905
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Hyphal induction in the human fungal pathogen Candida albicans reveals a characteristic wall protein profile.

Heilmann CJ, Sorgo AG, Siliakus AR, Dekker HL, Brul S, de Koster CG, de Koning LJ, Klis FM.

Microbiology. 2011 Aug;157(Pt 8):2297-307. doi: 10.1099/mic.0.049395-0. Epub 2011 May 20.

PMID:
21602216
[PubMed - indexed for MEDLINE]
Free Article
3.

Carbon source-induced reprogramming of the cell wall proteome and secretome modulates the adherence and drug resistance of the fungal pathogen Candida albicans.

Ene IV, Heilmann CJ, Sorgo AG, Walker LA, de Koster CG, Munro CA, Klis FM, Brown AJ.

Proteomics. 2012 Nov;12(21):3164-79. doi: 10.1002/pmic.201200228.

PMID:
22997008
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.

Sanati H, Belanger P, Fratti R, Ghannoum M.

Antimicrob Agents Chemother. 1997 Nov;41(11):2492-6.

PMID:
9371355
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Mitochondrial sorting and assembly machinery subunit Sam37 in Candida albicans: insight into the roles of mitochondria in fitness, cell wall integrity, and virulence.

Qu Y, Jelicic B, Pettolino F, Perry A, Lo TL, Hewitt VL, Bantun F, Beilharz TH, Peleg AY, Lithgow T, Djordjevic JT, Traven A.

Eukaryot Cell. 2012 Apr;11(4):532-44. doi: 10.1128/EC.05292-11. Epub 2012 Jan 27.

PMID:
22286093
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Hypoxic conditions and iron restriction affect the cell-wall proteome of Candida albicans grown under vagina-simulative conditions.

Sosinska GJ, de Groot PW, Teixeira de Mattos MJ, Dekker HL, de Koster CG, Hellingwerf KJ, Klis FM.

Microbiology. 2008 Feb;154(Pt 2):510-20. doi: 10.1099/mic.0.2007/012617-0.

PMID:
18227255
[PubMed - indexed for MEDLINE]
Free Article
7.

Mass spectrometric quantification of the adaptations in the wall proteome of Candida albicans in response to ambient pH.

Sosinska GJ, de Koning LJ, de Groot PW, Manders EM, Dekker HL, Hellingwerf KJ, de Koster CG, Klis FM.

Microbiology. 2011 Jan;157(Pt 1):136-46. doi: 10.1099/mic.0.044206-0. Epub 2010 Sep 23.

PMID:
20864472
[PubMed - indexed for MEDLINE]
Free Article
8.

A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.

Dunkel N, Liu TT, Barker KS, Homayouni R, Morschhäuser J, Rogers PD.

Eukaryot Cell. 2008 Jul;7(7):1180-90. doi: 10.1128/EC.00103-08. Epub 2008 May 16.

PMID:
18487346
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Molecular determinants of the interaction between human high molecular weight kininogen and Candida albicans cell wall: Identification of kininogen-binding proteins on fungal cell wall and mapping the cell wall-binding regions on kininogen molecule.

Karkowska-Kuleta J, Kedracka-Krok S, Rapala-Kozik M, Kamysz W, Bielinska S, Karafova A, Kozik A.

Peptides. 2011 Dec;32(12):2488-96. doi: 10.1016/j.peptides.2011.10.021. Epub 2011 Oct 28.

PMID:
22074954
[PubMed - indexed for MEDLINE]
10.

Mechanism of the synergistic effect of amiodarone and fluconazole in Candida albicans.

Gamarra S, Rocha EM, Zhang YQ, Park S, Rao R, Perlin DS.

Antimicrob Agents Chemother. 2010 May;54(5):1753-61. doi: 10.1128/AAC.01728-09. Epub 2010 Mar 1.

PMID:
20194694
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Expression analysis of SIR2 and SAPs1-4 gene expression in Candida albicans treated with allicin compared to fluconazole.

Khodavandi A, Alizadeh F, Harmal NS, Sidik SM, Othman F, Sekawi Z, Chong PP.

Trop Biomed. 2011 Dec;28(3):589-98.

PMID:
22433888
[PubMed - indexed for MEDLINE]
Free Article
12.

The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.

Borecká-Melkusová S, Moran GP, Sullivan DJ, Kucharíková S, Chorvát D Jr, Bujdáková H.

Mycoses. 2009 Mar;52(2):118-28. doi: 10.1111/j.1439-0507.2008.01550.x. Epub 2008 Jun 21.

PMID:
18627475
[PubMed - indexed for MEDLINE]
13.

Mass spectrometric analysis of the secretome of Candida albicans.

Sorgo AG, Heilmann CJ, Dekker HL, Brul S, de Koster CG, Klis FM.

Yeast. 2010 Aug;27(8):661-72. doi: 10.1002/yea.1775.

PMID:
20641015
[PubMed - indexed for MEDLINE]
14.

Surface stress induces a conserved cell wall stress response in the pathogenic fungus Candida albicans.

Heilmann CJ, Sorgo AG, Mohammadi S, Sosinska GJ, de Koster CG, Brul S, de Koning LJ, Klis FM.

Eukaryot Cell. 2013 Feb;12(2):254-64. doi: 10.1128/EC.00278-12. Epub 2012 Dec 14.

PMID:
23243062
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Identification and functional characterization of Rca1, a transcription factor involved in both antifungal susceptibility and host response in Candida albicans.

Vandeputte P, Pradervand S, Ischer F, Coste AT, Ferrari S, Harshman K, Sanglard D.

Eukaryot Cell. 2012 Jul;11(7):916-31. doi: 10.1128/EC.00134-12. Epub 2012 May 11.

PMID:
22581526
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The effect of plagiochin E alone and in combination with fluconazole on the ergosterol biosynthesis of Candida albicans.

Sun LM, Lv BB, Cheng AX, Wu XZ, Lou HX.

Biol Pharm Bull. 2009 Jan;32(1):36-40. Retraction in: Sun LM. Biol Pharm Bull. 2009 Jun;32(6):1135.

PMID:
19122277
[PubMed - indexed for MEDLINE]
Free Article
17.

Identification of major glucan-associated cell wall proteins of Candida albicans and their role in fluconazole resistance.

Angiolella L, Micocci MM, D'Alessio S, Girolamo A, Maras B, Cassone A.

Antimicrob Agents Chemother. 2002 Jun;46(6):1688-94.

PMID:
12019077
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Effects of fluconazole on the sterol and carbohydrate composition of four species of Candida.

Pfaller M, Riley J.

Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):152-6.

PMID:
1396728
[PubMed - indexed for MEDLINE]
19.

Antimicrobial peptides enhance the candidacidal activity of antifungal drugs by promoting the efflux of ATP from Candida cells.

Tanida T, Okamoto T, Ueta E, Yamamoto T, Osaki T.

J Antimicrob Chemother. 2006 Jan;57(1):94-103. Epub 2005 Nov 16.

PMID:
16291868
[PubMed - indexed for MEDLINE]
Free Article
20.

An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans.

Heilmann CJ, Schneider S, Barker KS, Rogers PD, Morschhäuser J.

Antimicrob Agents Chemother. 2010 Jan;54(1):353-9. doi: 10.1128/AAC.01102-09. Epub 2009 Nov 2.

PMID:
19884367
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk